Gilead Sciences, Inc.
Imidazopyrimidine derivatives
Last updated:
Abstract:
The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating cancers.
Status:
Grant
Type:
Utility
Filling date:
2 Oct 2019
Issue date:
23 Nov 2021